|
|
 |
|
Viewing report
|
|
 |
 |
Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China
Frost & Sullivan, July 2005
International Pharmaceutical Companies Develop Research Base in India and China
Beleaguered by ever-increasing cost pressures, shorter product life cycles and various regulatory challenges in the West, the pharmaceutical industry is turning to opportunities in low-cost Asian countries such as India and China. Alliances with local companies, contractual outsourcing arrangements and establishment of local subsidiaries enable these enterprises to access openings in both countries, especially in the area of pharmaceutical research and development (R&D).
This service analyses the advantages and disadvantages of pharma R&D outsourcing to India and China. The study discusses the various trends and opportunities in each country while providing in-depth market share analysis, forecasts, drivers, restraints, and revenue forecasts. It also enables companies to align their positioning strategies to benefit from the changing environment and obtain maximum return on investment.
Customers who bought this item also bought
Clinical Trials in India
Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
Clinical Research Outsourcing and India
Comparison of Pharma Outsourcing between China and India
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China
Industry Insight Clinical Trials in India
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
Central and Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials
Drug Discovery Outsourcing Market in India and China
China Pharma Outsourcing Market By 2015
Pharmaceutical Outsourcing Strategies: Market Expansion, Offshoring and Strategic Management in the CRO and CMO Marketplace
|
 |
|
|